LEGN (Legend Biotech) Accounts Payable: $77 Mil (As of Jun. 2026)

Author: Vera Yuan Vera Yuan
Vera Yuan
Vera Yuan
Director of Data and Quant Analytics at GuruFocus
Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Reviewed by: Charlie Tian Charlie Tian
Charlie Tian
Charlie Tian
Founder & CEO of GuruFocus
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.

LEGN Legend Biotech Corp LEGN
71 GF Score
Price $21.59
GF Value $79.83
Valuation Significantly Undervalued
! 2 Warning Signs
View Full Analysis

What is Legend Biotech Accounts Payable?

Legend Biotech LEGN -0.78% 71 Accounts Payable is $77 Mil as of Jun. 2026. GuruFocus rates LEGN with a GF Score™ of 71/100 and a GF Value™ of $79.83 (Significantly Undervalued). The stock has 2 warning signs investors should review.

Legend Biotech's Accounts Payable for the quarter that ended in Jun. 2026 was $77 Mil.

Legend Biotech's quarterly Accounts Payable declined from Dec. 2025 ($81 Mil) to Mar. 2026 ($74 Mil) but then increased from Mar. 2026 ($74 Mil) to Jun. 2026 ($77 Mil).

Legend Biotech's annual Accounts Payable increased from Dec. 2023 ($30 Mil) to Dec. 2024 ($37 Mil) and increased from Dec. 2024 ($37 Mil) to Dec. 2025 ($81 Mil).

Legend Biotech Accounts Payable Related Terms

Legend Biotech Accounts Payable Historical Data

* Premium members only.

The historical data trend for Legend Biotech's Accounts Payable can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Legend Biotech Accounts Payable Chart

Legend Biotech Annual Data
Trend Dec18 Dec19 Dec20 Dec21 Dec22 Dec23 Dec24 Dec25
Accounts Payable
Get a 7-Day Free Trial 7.04 31.69 30.06 37.20 81.20

Legend Biotech Quarterly Data
Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Sep24 Dec24 Mar25 Jun25 Sep25 Dec25 Mar26 Jun26
Accounts Payable Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 75.36 102.46 81.20 74.30 77.30
LEGN
71GF Score
Legend Biotech Corp LEGN
Accounts Payable is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

Legend Biotech Accounts Payable Calculation

Accounts Payable represents any money that a company owes its suppliers for goods and services purchased on credit and is expected to pay within the next year or operating cycle.

Frequently Asked Questions Learn more about Accounts Payable →
What does a Accounts Payable of $77 Mil mean?
Legend Biotech (LEGN) has a Accounts Payable of $77 Mil as of Jun. 2026. Accounts Payable is any money that a company owes for goods and services purchased on credit and is expected to pay within the next year. View historical data on Legend Biotech and its competitors.
Is Legend Biotech's Accounts Payable too high?
Legend Biotech's current Accounts Payable is $77 Mil. Overall, Legend Biotech has a GF Score™ of 71/100 and is considered Significantly Undervalued, reflecting its overall financial health beyond just this single metric.
How does Legend Biotech's Accounts Payable compare to IDYA and DNLI?
Legend Biotech's Accounts Payable of $77 Mil can be compared against companies in the Biotechnology industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Accounts Payable for a Biotechnology company?
A good Accounts Payable depends on the Biotechnology industry context. However, Accounts Payable should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Accounts Payable mean?
A high Accounts Payable can signal that a stock is expensive relative to its fundamentals. Accounts Payable is any money that a company owes for goods and services purchased on credit and is expected to pay within the next year. View historical data on Legend Biotech and its competitors. Legend Biotech's current Accounts Payable is $77 Mil. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Legend Biotech stock overvalued right now?
Based on GuruFocus' analysis, Legend Biotech (LEGN) is currently considered Significantly Undervalued. The stock's GF Value™ is $79.83, compared to a current price of $21.59 — trading 73% below its estimated fair value. The current Accounts Payable is $77 Mil. Legend Biotech's overall GF Score™ is 71/100 with 2 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Accounts Payable calculated?
Accounts Payable is calculated from a company's financial statements. For Legend Biotech (LEGN), the current Accounts Payable is $77 Mil as of Jun. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Is Legend Biotech (LEGN) Overvalued in 2026?

Based on GuruFocus' analysis, Legend Biotech stock appears to be undervalued. The current stock price of $21.59 is trading 73% below its estimated GF Value™ of $79.83. GuruFocus considers Legend Biotech to be Significantly Undervalued.

Key valuation signals for LEGN:

  • Accounts Payable: $77 Mil
  • GF Value™: $79.83 vs. price of $21.59 (73% below fair value)
  • GF Score™: 71/100 with 2 warning signs

No single metric tells the full story. See the LEGN stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.

Legend Biotech Business Description

Other Exchanges 9LB:Germany
Address 2101 Cottontail Lane, Somerset, NJ, USA, 08873
Legend Biotech Corp is a clinical-stage biopharmaceutical company. It is engaged in the discovery and development of novel cell therapies for oncology and other indications. The firm's product candidate, LCAR-B38M/JNJ-4528, is a chimeric antigen receptor, or CAR, T cell therapy for the treatment of multiple myeloma. Geographically, the company generates a majority of its revenue from the United States of America. The company generates revenue from License and Collaboration revenue.
71GF Score

Get the complete analysis for LEGN

Accounts Payable is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

$21.59
Price
$79.83
GF Value